Treatment of Axillosubclavian Vein Thrombosis: A Novel Technique for Rapid Removal of Clot Using Low-Dose Thrombolysis

Abstract

Purpose:

To report successful combined percutaneous mechanical thrombectomy and pharmacological lysis for axillosubclavian vein thrombosis, with rapid clot removal at a single setting using low-dose thrombolysis.

Case Reports:

Two consecutive patients presented with arm swelling; the diagnosis of axillosubclavian vein thrombosis was confirmed with duplex ultrasound. Both patients were treated percutaneously with the Solera mechanical thrombectomy device, after which 5 mg of tissue plasminogen activator were delivered within ∼10 minutes via the Trellis infusion catheter to remove any residual thrombus. Completion venography and serial duplex ultrasound scans in follow-up demonstrated widely patent axillosubclavian veins with no residual thrombus in both cases.

Conclusions:

Standard treatment of axillosubclavian vein thrombosis may require 12 to 36 hours, with multiple trips to the angiography suite. The novel technique combining mechanical thrombectomy and pharmacological lysis can be performed safely and successfully at a single setting with a small dose of the lytic drug.

Keywords

axillosubclavian vein upper extremity vein thrombosis mechanical thrombectomy thrombolysis tissue plasminogen activator Solera Bacchus Thrombectomy Catheter Trellis Infusion System

Get full access to this article

View all access options for this article.

References

Azakie

McElhinney

Thompson

. Surgical management of subclavian vein effort thrombosis as a result of thoracic outlet compression. J Vasc Surg. 1998; 28: 777–786.

Beygui

Olcott

4th Dalman

. Subclavian vein thrombosis: Outcome analysis based on the etiology and modality of treatment. Ann Vasc Surg. 1997; 11: 247–255.

Bolitho

Elwood

Roberts

. Phlegmasia cerulea dolens of the upper extremity. Ann Plast Surg. 2000; 45: 644–646.

Hingorani

Ascher

Lorenson

. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997; 26: 853–860.

Monreal

Raventos

Lerma

. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines- a prospective study. Thromb Haemost. 1994; 72: 548–550.

Gloviczki

Kazmier

Hollier

. Axillary-subclavian venous occlusion: The morbidity of a nonlethal disease. J Vasc Surg. 1986; 4: 333–337.

Ellis

Manor

Witz

. Risk factors and management of patients with upper limb deep vein thrombosis. Chest. 2000; 117: 43–46.

Rutherford

. Primary subclavian-axillary vein thrombosis: The relative roles of thrombolysis, percutaneous angioplasty, stent, and surgery. Semin Vasc Surg. 1998; 11: 91–95.

Schweizer

Kirch

Koch

. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000; 36: 1336–1343.

10.

Angle

Gelabert

Farooq

. Safety and efficacy of early surgical decompression of the thoracic outlet for Paget-Schroetter syndrome. Ann Vasc Surg. 2001; 15: 37–42.

11.

Chang

Horne

Mayo

. Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator. J Vasc Interv Radiol. 1996; 7: 845–851.

12.

Adelman

Stone

Riles

. A multidisciplinary approach to the treatment of Paget-Schroetter syndrome. Ann Vasc Surg. 1997; 11: 149–154.

13.

Semba

. Venous thrombolysis in the post-urokinase era. Tech Vasc Interv Radiol. 2000; 3: 2–11.

14.

Valji

. Evolving strategies for thrombolytic therapy of peripheral vascular occlusion. J Vasc Interv Radiol. 2000; 11: 411–420.

15.

Benenati

Shlansky-Goldberg

Meglin

. Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab: The SCVIR consultants' conference. May 22, 2000; Orlando, FL. Society for Cardiovascular and Interventional Radiology. J Vasc Interv Radiol. 2001; 12: 795–805.